Author: Scott Welch
The U.S. Supreme Court is considering jointly two cases, Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce, that could affect the impact of federal regulations in implementing laws passed by Congress. Although these cases are focused on regulations pertaining to the fishing industry, the court’s decision could have significant implications for numerous other policy ...
The DOL's latest iteration, proposed in 2023 and soon to become final, will ensure that advisors prioritize their clients' best interests when recommending investments, prompting employers to make necessary adjustments.
The fallout from a February cyberattack against Change Healthcare, the largest billing and payment system in the U.S., has left thousands of doctor practices financially hurting, with 80% of physicians reporting “lost revenue from unpaid claims,” according to a survey by the American Medical Association. The AMA, which is the nation’s largest doctor group, said ...
Tax day is here. While Americans are scrambling to file last minute returns, things are somewhat more complicated for corporations. Corporations are supposed to pay a nominal tax rate of 21%. But in recent years, the biggest pharmaceutical companies had an average effective tax rate of less than 12%, according to an analysis by the Senate Finance ...
A major House subcommittee is considering 15 bills to expand access to telehealth services as the clock ticks on a Dec. 31 deadline on pandemic-era flexibilities. The American Telemedicine Association has referred to 2024 as the “Super Bowl” of telehealth regulation as the trade group pushes Congress to make permanent the Medicare telehealth flexibilities implemented during the COVID-19 pandemic. ...
If you’re feeling — YAWN — sleepy or tired while you read this and wish you could get some more shut-eye, you’re not alone. A majority of Americans say they would feel better if they could have more sleep, according to a new poll. But in the U.S., the ethos of grinding and pulling yourself ...
Prescriptions for biosimilar versions of AbbVie’s Humira (adalimumab) have spiked to 36% after leading pharmacy benefit manager CVS Caremark removed the branded reference product from its major national commercial formularies, according to STAT News. Citing a note to investors by analyst firm Evercore ISI, STAT reported that in the week ending April 5, there were almost 8,300 new prescriptions for Sandoz’s ...
The rule, which was proposed last summer as part of a series of actions aimed at lowering health care costs, limits the duration of new sales of these controversial plans to three months with the option of renewal for a maximum of four months total, the administration said Thursday.
Instead of enacting public option plans, states should target reinsurance programs, a new report from the Partnership for America's Health Care Future argues.
Battle Mountain (Nev.) General Hospital reported a data breach affecting around 3,000 patients in late March, according to HHS.